Distributed Biological Reasoning

Distributed biological reasoning is a multi-agent method for interpreting large biological experiments. It divides a dataset into perturbation-specific investigations, then combines the resulting reports into an evidence-linked reasoning atlas. OpenAI, PerturbAI and Scripps Research described the approach publicly on October 21, 2026, using GPT-Rosalind agents to investigate existing mouse-brain experimental data.^[1]

The method was studied in Alexander Sun and colleagues' preprint, Distributed AI agents enable comprehensive discovery of biological insights at scale, posted to bioRxiv on October 16, 2026. Its results concern computational interpretation and research prioritization, not demonstrated treatments.^[2]

Experimental data

The underlying whole-brain CRISPR atlas combines gene perturbations with single-cell RNA sequencing measurements in mice. Its public dataset card reports approximately 7.7 million cells, 19,070 measured mRNAs and 8,588 single-guide RNAs. Cell metadata include targeted genes, cell classifications, anatomical regions and quality-control indicators.^[3]

The resource contains several formats for different analysis workflows: cell-level Parquet files, separate metadata tables, AnnData shards and a Zarr archive. These are experimental measurements and annotations; the reasoning atlas adds interpretations of their biological meaning rather than replacing the source data.^[3][4]

How the framework works

The authors' DistributedAgents repository implements a pipeline that assigns independent agents to individual perturbations. Each investigation combines cell-type-resolved expression information with literature retrieval and produces both narrative and structured outputs. Subsequent synthesis compares reports to identify shared responses, opposing effects and hypotheses worth reviewing.^[4]

The released implementation separates report construction from querying existing corpora. Its build command generates source reports; query investigates a corpus; chat provides a persistent terminal session; and corpus inspects installed releases. Report construction validates structured ledgers and records model, prompt and schema identifiers in run manifests.^[5]

The software is therefore more than a single prompt applied to the complete dataset. Its saved reports and structured evidence support subsequent retrieval and analysis without requiring every question to repeat the initial investigation.^[4][5]

Reported evaluation

Sun and colleagues ran 1,946 parallel agents with GPT-Rosalind-5.5. They withheld the original experimental manuscript and its conclusions.^[2]

The blinded comparison involved 20 matched report pairs, each assessed by three experts. These are report preferences within the study, not a general accuracy score for biology.^[2]

OpenAI reported a 32-minute parallel analysis. Its comparison with months to a year of human work was an estimate, not a timed human trial.^[1][2]

Biological research leads

One example concerned Tsc1 and Tsc2, genes involved in regulating mTOR. OpenAI described similar perturbation responses in several neuronal groups but different responses in cerebellar cells. The agents identified this difference as a lead for investigating cell-specific disease biology.^[1]

Another example concerned Dctn1. Its disruption was associated with increased expression of cholesterol-biosynthesis genes in the atlas. The agents connected this observation with literature on intracellular transport and proposed investigating whether altered cholesterol distribution could explain the response. The proposed mechanism requires follow-up experiments; a plausible explanation of an expression pattern does not establish a therapy.^[1][2]

Evidence limits

The preprint calls for evaluation on independent datasets and prospective experiments. Its literature labels also require care: failure to retrieve precedent does not establish novelty, and the authors identified an inference that transferred expectations incorrectly between biological contexts.^[2]

The work interprets already collected mouse data. Its research leads do not demonstrate clinical benefit in people.^[1][2]

Public research materials

The authors released the DistributedAgents software and accompanying documentation under the MIT License. The repository includes saved reports, prompts, measurements, preparation code and figure notebooks. Its instructions distinguish reproducing saved manuscript analyses from making new model calls; reproducing those saved analyses does not require API credentials.^[4]

The repository also documents a hosted read-only corpus service accessible through the Model Context Protocol. That service exposes findings, claims and supporting evidence, but does not include the raw experimental files needed to recompute dataset statistics. Local use therefore has a different data-access scope from querying the hosted corpus.^[4]

References

1. ^1 ^2 ^3 ^4 ^5OpenAI. "Using thousands of AI agents to uncover new leads in biological data." October 21, 2026.
2. ^1 ^2 ^3 ^4 ^5 ^6 ^7Sun, A., Park, J. J., DeTomaso, D., et al. "Distributed AI agents enable comprehensive discovery of biological insights at scale." bioRxiv, October 16, 2026. DOI: 10.64898/2026.10.15.759436. Preprint.
3. ^1 ^2PerturbAI. "PerturbAI Brain-Wide In Vivo CRISPR Atlas." Dataset card. Accessed October 23, 2026.
4. ^1 ^2 ^3 ^4 ^5Jin Lab Neurogenomics. "Distributed Agents." Research repository and README. Accessed October 23, 2026.
5. ^1 ^2Jin Lab Neurogenomics. "DistributedAgents runtime documentation." Accessed October 23, 2026.